Multiple early factors anticipate post-acute COVID-19 sequelae
Su Y, et al.
Cell
February 2022
Authors and Affiliates
Yapeng Su 1, Dan Yuan 2, Daniel G Chen 3, Rachel H Ng 2, Kai Wang 4, Jongchan Choi 4, Sarah Li 4, Sunga Hong 4, Rongyu Zhang 2, Jingyi Xie 5, Sergey A Kornilov 4, Kelsey Scherler 4, Ana Jimena Pavlovitch-Bedzyk 6, Shen Dong 7, Christopher Lausted 4, Inyoul Lee 4, Shannon Fallen 4, Chengzhen L Dai 4, Priyanka Baloni 4, Brett Smith 4, Venkata R Duvvuri 4, Kristin G Anderson 8, Jing Li 6, Fan Yang 9, Caroline J Duncombe 10, Denise J McCulloch 11, Clifford Rostomily 4, Pamela Troisch 4, Jing Zhou 12, Sean Mackay 12, Quinn DeGottardi 13, Damon H May 13, Ruth Taniguchi 13, Rachel M Gittelman 13, Mark Klinger 13, Thomas M Snyder 13, Ryan Roper 4, Gladys Wojciechowska 14, Kim Murray 4, Rick Edmark 4, Simon Evans 4, Lesley Jones 4, Yong Zhou 4, Lee Rowen 4, Rachel Liu 4, William Chour 4, Heather A Algren 15, William R Berrington 15, Julie A Wallick 15, Rebecca A Cochran 15, Mary E Micikas 15, ISB-Swedish COVID-19 Biobanking Unit 4; Terri Wrin 16, Christos J Petropoulos 16, Hunter R Cole 17, Trevan D Fischer 17, Wei Wei 4, Dave S B Hoon 17, Nathan D Price 4, Naeha Subramanian 18, Joshua A Hill 19, Jennifer Hadlock 4, Andrew T Magis 4, Antoni Ribas 20, Lewis L Lanier 21, Scott D Boyd 9, Jeffrey A Bluestone 7, Helen Chu 22, Leroy Hood 23, Raphael Gottardo 24, Philip D Greenberg 8, Mark M Davis 25, Jason D Goldman 26, James R Heath 27;
1 Institute for Systems Biology, Seattle, WA 98109, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Clinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. Electronic address: suyapeng.tju@gmail.com.
2 Institute for Systems Biology, Seattle, WA 98109, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA.
3 Institute for Systems Biology, Seattle, WA 98109, USA; Department of Microbiology and Department of Informatics, University of Washington, Seattle, WA 98195, USA.
4 Institute for Systems Biology, Seattle, WA 98109, USA.
5 Institute for Systems Biology, Seattle, WA 98109, USA; Molecular Engineering & Sciences Institute, University of Washington, Seattle, WA 98105, USA.
6 Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA.
7 Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA.
8 Clinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Departments of Immunology and Medicine, University of Washington, Seattle, WA 98109, USA.
9 Department of Pathology, Stanford University, Stanford, CA 94304, USA.
10 Division of Global Health, University of Washington, Seattle, WA 98105, USA.
11 Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.
12 Isoplexis Corporation, Branford, CT 06405, USA.
13 Adaptive Biotechnologies, Seattle, WA 98109, USA.
14 Institute for Systems Biology, Seattle, WA 98109, USA; Medical University of Białystok, Białystok 15089, Poland.
15 Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.
16 Monogram Biosciences, South San Francisco, CA 94080, USA.
17 St. John's Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA.
18 Institute for Systems Biology, Seattle, WA 98109, USA; Department of Global Heath and Department of Immunology, University of Washington, Seattle, WA 98109, USA.
19 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.
20 Department of Medicine, University of California, Los Angeles, and Parker Institute for Cancer Immunotherapy, Los Angeles, CA 90095, USA.
21 Department of Microbiology and Immunology, University of California, San Francisco, and Parker Institute for Cancer Immunotherapy, San Francisco, CA 94143, USA.
22 Division of Global Health, University of Washington, Seattle, WA 98105, USA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.
23 Institute for Systems Biology, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA.
24 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Department of Statistics, University of Washington, Seattle, WA 98195, USA; Biomedical Data Sciences, Lausanne University Hospital, University of Lausanne, Lausanne, 1011, Switzerland.
25 Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; The Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
26 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA; Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, WA 98109, USA; Providence St. Joseph Health, Renton, WA 98057, USA. Electronic address: jason.goldman@swedish.org.
27 Institute for Systems Biology, Seattle, WA 98109, USA; Department of Bioengineering, University of Washington, Seattle, WA 98105, USA. Electronic address: jim.heath@isbscience.org.